Bing Du

13PUBLICATIONS
20CO-AUTHORS
Molecular targetsReaction engineering (excl. nuclear reactions)Micro- and nanosystemsCancer therapy (excl. chemotherapy and radiation therapy)Psychophysiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 12, 2025
Genome editing or small molecule inhibition of KMT5A in CAR-T cells enhances antitumor immunity.

Xiaoling Tian, Guolong Liu, Qiudao Wang

|Mar 31, 2025
Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo.

Huiying Li, Yuhao Qiu, Bowen Song

|Mar 08, 2025
Optimization of Lipid Nanoparticles with Robust Efficiency for the Delivery of Protein Therapeutics to Augment Cancer Immunotherapy.

Lanfang Ren, Zeda Zhao, Yuqing Chao

|Aug 31, 2022
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL.

Jiqin Zhang, Yongxian Hu, Jiaxuan Yang

|Feb 28, 2022
Neuroendocrine Regulation of Stress-Induced T Cell Dysfunction during Lung Cancer Immunosurveillance via the Kisspeptin/GPR54 Signaling Pathway.

Su Zhang, Fangfei Yu, Anran Che

|Aug 11, 2021
Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies.

Yan Lou, Wenxiang Zhao, Haitao Wei

Pageof 3